Skip to main content
. 2004 Oct;10(10):1812–1815. doi: 10.3201/eid1010.040335

Figure 1.

Figure 1

Incidence (cases/100,000/year) of meningococcal disease (average rates 1985–2000) in relation to serogroup C and W135 bactericidal antibody titers in British Columbia against a local ST11 outbreak isolate (AOBZ1379) and Z1582/FC978 (a Canadian clinical isolate from 2000 bearing the W135 capsule), respectively.